Trial Details
COMPLETEDBasic Information
| Clinical ID | c2107 |
|---|---|
| Identifier | NCT03962998 |
| Trial Title | Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Lactulose/Rhamnose solution|DRUG: MB-102 |
Participant Information
| Sponsor | MediBeacon |
|---|---|
| City | St Louis |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | EARLY_PHASE1 |
Time Information
| Start Date | 2019-10-27 |
|---|---|
| Primary Completion Date | 2021-10-05 |
| Completion Date | 2021-10-05 |